Sign In
5 Jan 2010 07:00
Cyprotex PLC
("Cyprotex" or "the Company" or "the Group")
Trading Update
Cyprotex (LSE:CRX), the drug discovery technology and information company, notes yesterday's fall in the share price and is unaware of any reason for this share price movement. The Company re-iterates that its current trading is in line with market expectations following its trading update of 20 November 2009.
The Company expects to release a trading update towards the end of January 2010, in respect of calendar year ended 31 December 2009.
For further information:
|
Cyprotex PLC |
Tel: +44 (0) 1625 505 100 |
|
|
Dr Anthony Baxter, Chief Executive Officer John Dootson, Chief Financial Officer |
||
|
ir@cyprotex.com |
www.cyprotex.com |
|
|
Noble & Company |
Tel: +44 (0) 20 7763 2200 |
|
|
John Llewellyn-Lloyd john.llewellyn-lloyd@noblegp.com |
www.noblegp.com |
|
|
Financial Dynamics |
Tel: +44 (0) 20 7831 3113 |
|
|
Ben Brewerton / Ben Atwell / John Dineen |
||
|
cyprotex@fd.com |
www.fd.com |
|
CRX.L (CRX)
Follow the stocks
